Pembro Boosts Treatment Impact in Advanced Breast Cancer

Adding pembrolizumab to trastuzumab in treatment-resistant advanced breast cancer appears to reactivate the immune response and achieve a clinical benefit, early-phase trial data suggest.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply